Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-234370
Filing Date
2012-05-15
Accepted
2012-05-15 15:40:08
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d330086d10q.htm 10-Q 367555
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d330086dex311.htm EX-31.1 10344
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d330086dex312.htm EX-31.2 10346
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d330086dex321.htm EX-32.1 4378
  Complete submission text file 0001193125-12-234370.txt   1809032

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT onvo-20120331.xml EX-101.INS 210001
6 XBRL TAXONOMY EXTENSION SCHEMA onvo-20120331.xsd EX-101.SCH 14921
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onvo-20120331_cal.xml EX-101.CAL 33993
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onvo-20120331_def.xml EX-101.DEF 15284
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE onvo-20120331_lab.xml EX-101.LAB 145788
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onvo-20120331_pre.xml EX-101.PRE 89212
Mailing Address 5871 OBERLIN DR. SUITE 150 SAN DIEGO CA 92121
Business Address 5871 OBERLIN DR. SUITE 150 SAN DIEGO CA 92121 858-550-9994
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54621 | Film No.: 12844196
SIC: 2836 Biological Products, (No Diagnostic Substances)